Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 10Terminated 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3CNS 3

Conditions

Squamous Cell Carcinoma of Head and Neck 15Head and Neck Neoplasms 10Prostatic Neoplasms 8Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Glioblastoma 4Urinary Bladder Neoplasms 3Sarcoma 3Oropharyngeal Neoplasms 3Lymphoma, Extranodal NK-T-Cell 3Kidney Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Neoplasm Metastasis 2Mesothelioma, Malignant 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Glioma 2Congenital Abnormalities 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Astrocytoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Vomiting 1Uterine Cervical Neoplasms 1Stage IA Uterine Sarcoma 1Squamous Cell Carcinoma of Anal Canal 1

Interventions

Temozolomide 19Radiotherapy 11Bevacizumab 7Radiation 4Irinotecan 4Erlotinib Hydrochloride 4carmustine, poliferprosan 20 drug combination 3Radiotherapy, Intensity-Modulated 3O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Carmustine 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3Vorinostat 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiosurgery 2Gadolinium DTPA 2Filgrastim 2Drug Therapy 2Congresses as Topic 2Cilengitide 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vitespin 1sargramostim 1sapanisertib 1poly ICLC 1plerixafor 1picropodophyllin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Gliosarcoma × Radiotherapy, Intensity-Modulated × Clear all
NCT04397679 2025-01-15

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Barbara Ann Karmanos Cancer Institute

Phase 1 Terminated
2 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00669669 2022-05-18

O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
12 enrolled 13 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02394665 2017-01-05

Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma

University of Miami

Phase 2 Terminated
1 enrolled 3 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡